logo
Select company
Select metric
$ 0Net Income to Non-Controlling Interests
VS
Market
10
Sector
8
Industry
7
History
-
$ 12.03Close
$ 4.13 - $ 14.24 52-Week Range
Ticker Information

Ticker

EYPT

Company Name

EYEPOINT PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

EYEPOINT PHARMACEUTICALS INC - Net Income to Non-Controlling Interests Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

EYPT - Net Inc. NCI Historical data
DateNet Income to Non-Controlling Interests
6/30/2025$ 0
3/31/2025$ 0
12/31/2024$ 0
9/30/2024$ 0
6/30/2024$ 0
3/31/2024$ 0
12/31/2023$ 0
9/30/2023$ 0
6/30/2023$ 0
3/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • EYEPOINT PHARMACEUTICALS INC's latest trailing twelve months (TTM) Net Inc. NCI stands at $ 0.
  • Over the past 5 years, EYEPOINT PHARMACEUTICALS INC's average Net Inc. NCI has been $ 0.
  • The median Net Inc. NCI for EYEPOINT PHARMACEUTICALS INC during this period was $ 0
  • EYEPOINT PHARMACEUTICALS INC reached its highest Net Inc. NCI over the past 5 years at $ 0.
  • The lowest Net Inc. NCI recorded by EYEPOINT PHARMACEUTICALS INC in the same timeframe $ 0

EYEPOINT PHARMACEUTICALS INC's Net Inc. NCI vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Net Inc. NCI Benchmarks
CompanyNet Inc. NCI
ZVRA : ZEVRA THERAPEUTICS INC $ 0MGTX : MEIRAGTX HOLDINGS PLC $ 0GOSS : GOSSAMER BIO INC $ 0LXRX : LEXICON PHARMACEUTICALS INC $ 0SAGE : SAGE THERAPEUTICS INC $ 0TBPH : THERAVANCE BIOPHARMA INC $ 0XOMA : XOMA ROYALTY CORP $ 2.74MAUTL : AUTOLUS THERAPEUTICS PLC $ 0TNGX : TANGO THERAPEUTICS INC $ 0VIR : VIR BIOTECHNOLOGY INC $ 0

Definition of Net Income to Non-Controlling Interests

[Income Statement] The portion of income which is attributable to non-controlling interest shareholders; subtracted from [ConsolInc] in order to obtain [NetInc].

EYPT - Net Income to Non-Controlling Interests, Last 5 years

$ 0

Minimum

Sep 30, 2020

$ 0

Maximum

Sep 30, 2020

$ 0

Average

$ 0

Median

Net Inc. NCI Benchmark Analysis

The chart above depicts the distribution of Net Inc. NCI for companies in the Total Stock Market. The average Net Inc. NCI of the companies is $ 11.09M with a standard deviation of $ 136.42M.
The following table provides additional summary stats:
Net Inc. NCI in the Market:
filtered constituents4.27K
min$ -1.8B
max$ 2.94B
average$ 11.09M
median$ 0
std$ 136.42M